Gentian Diagnostics presents at DNB conference in New York

05. Dec 2019 | 1 min read

Moss 05.12.19
The CEO of Gentian Diagnostics, Dr. Hilja Ibert, will today give a company presentation at the DNB Nordic American Life Science conference in New York. Please find the presentation attached.

For further information, please contact

Hilja Ibert CEO, Gentian Diagnostics AS
E-mail: hilja.ibert@gentian.no 
+47 919 05 242

Njaal Kind CFO, Gentian Diagnostics AS
E-mail: njaal.kind@gentian.no 
+47 919 06 525

You may also read


Feb 12, 2026 - Ole Sørlie

Gentian Diagnostics: Key information relating to the proposed cash dividend

Moss, 12 February 2026 The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK 0.60 per..

Feb 11, 2026 - Ole Sørlie

Update on the development of the NT-proBNP assay

Gentian Diagnostics ASA announces an update on the development of its NT proBNP assay. Recent investigations..

Feb 11, 2026 - Ole Sørlie

Gentian Diagnostics: Fourth quarter 2025 report

Moss, 11 February 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..